In this deep dive into Healthcare Policy & Regulation with Emily Evans, we discuss the Supreme Court's upcoming review of the Chevron deference and its likely effects on healthcare regulatory agencies including HHS, CMS, FDA and FTC. We also discuss the expected positive impact on healthcare M&A markets. While potential policy changes create short-term uncertainty, they also present opportunities for consolidation, competition, and innovation in the medium to long-term.
HF Site
YOUTUBE
INSTAGRAM
TWITTER
FACEBOOK
LINKEDIN
TIKTOK
